Loading company…
Fuzhou-based developer of antibodies and diagnostic reagents for immunohistochemical tumor pathology.
Based in Fuzhou, China, and established in 1993, MXB Biotechnologies develops, produces and sells monoclonal and polyclonal antibodies, detection systems, kits, the Lumatas staining instrument and the RedBright molecular pathology product for clinical tumor diagnosis. The company set up a quality control laboratory in 1999, holds a CFDA class III medical device production license and has 104 patents.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in